These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3391708

  • 1. Phenotypic resistance to methotrexate and N-phosphonacetyl L-aspartate is induced by treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kinsella AR, Fox M.
    Int J Cancer; 1988 Jul 15; 42(1):87-93. PubMed ID: 3391708
    [Abstract] [Full Text] [Related]

  • 2. TPA enhancement of the recovery of methotrexate and N-phosphonacetyl L-aspartate resistant mouse 3T6 cell clones is associated with transient alterations of cell cycle progression.
    Szallasi A, Fox M, Kinsella AR.
    Int J Cancer; 1988 Jul 15; 42(1):84-6. PubMed ID: 3391707
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 12-O-tetradecanoylphorbol-13-acetate on selection of drug-resistant phenotypes in rodent cells.
    Bojan F, Kinsella AR, Fox M.
    IARC Sci Publ; 1984 Jul 15; (56):265-73. PubMed ID: 6536598
    [Abstract] [Full Text] [Related]

  • 5. Increased methotrexate resistance and dhfr gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells.
    Wani MA, Xu X, Stambrook PJ.
    Cancer Res; 1994 May 01; 54(9):2504-8. PubMed ID: 8162600
    [Abstract] [Full Text] [Related]

  • 6. Phorbol ester dramatically increases incidence of methotrexate-resistant mouse cells: possible mechanisms and relevance to tumor promotion.
    Varshavsky A.
    Cell; 1981 Aug 01; 25(2):561-72. PubMed ID: 7285113
    [Abstract] [Full Text] [Related]

  • 7. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate.
    Hashimoto MW, Nikaido O, Kobayashi N, Chang CC, Trosko JE, Mori T.
    Carcinogenesis; 1996 Mar 01; 17(3):389-94. PubMed ID: 8631121
    [Abstract] [Full Text] [Related]

  • 8. Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes.
    Barsoum J, Varshavsky A.
    Proc Natl Acad Sci U S A; 1983 Sep 01; 80(17):5330-4. PubMed ID: 6351057
    [Abstract] [Full Text] [Related]

  • 9. Hamster cells with increased rates of DNA amplification, a new phenotype.
    Giulotto E, Knights C, Stark GR.
    Cell; 1987 Mar 13; 48(5):837-45. PubMed ID: 3815526
    [Abstract] [Full Text] [Related]

  • 10. Sp1 involvement in the 4beta-phorbol 12-myristate 13-acetate (TPA)-mediated increase in resistance to methotrexate in Chinese hamster ovary cells.
    Noé V, Alemany C, Nicolás M, Ciudad CJ.
    Eur J Biochem; 2001 Jun 13; 268(11):3163-73. PubMed ID: 11389717
    [Abstract] [Full Text] [Related]

  • 11. Inefficient growth arrest in response to dNTP starvation stimulates gene amplification through bridge-breakage-fusion cycles.
    Poupon MF, Smith KA, Chernova OB, Gilbert C, Stark GR.
    Mol Biol Cell; 1996 Mar 13; 7(3):345-54. PubMed ID: 8868464
    [Abstract] [Full Text] [Related]

  • 12. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells.
    Miele M, Bonatti S, Menichini P, Ottaggio L, Abbondandolo A.
    Mutat Res; 1989 May 13; 219(3):171-8. PubMed ID: 2567961
    [Abstract] [Full Text] [Related]

  • 13. Properties of single-step mutants of Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Zieg J, Clayton CE, Ardeshir F, Giulotto E, Swyryd EA, Stark GR.
    Mol Cell Biol; 1983 Nov 13; 3(11):2089-98. PubMed ID: 6656764
    [Abstract] [Full Text] [Related]

  • 14. Drug resistance in KHT fibrosarcoma cell lines with different metastatic ability.
    Cillo C, Ling V, Hill RP.
    Int J Cancer; 1989 Jan 15; 43(1):107-11. PubMed ID: 2910823
    [Abstract] [Full Text] [Related]

  • 15. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A, Wright JA.
    Oncogene; 1994 Feb 15; 9(2):491-9. PubMed ID: 7904743
    [Abstract] [Full Text] [Related]

  • 16. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.
    Paulson TG, Almasan A, Brody LL, Wahl GM.
    Mol Cell Biol; 1998 May 15; 18(5):3089-100. PubMed ID: 9566927
    [Abstract] [Full Text] [Related]

  • 17. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A, Fan H, Taylor WR, Wright JA.
    Cancer Res; 1997 Nov 01; 57(21):4876-81. PubMed ID: 9354452
    [Abstract] [Full Text] [Related]

  • 18. Structure of amplified DNA in different Syrian hamster cell lines resistant to N-(phosphonacetyl)-L-aspartate.
    Ardeshir F, Giulotto E, Zieg J, Brison O, Liao WS, Stark GR.
    Mol Cell Biol; 1983 Nov 01; 3(11):2076-88. PubMed ID: 6656763
    [Abstract] [Full Text] [Related]

  • 19. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
    Kündig C, Leblanc E, Papadopoulou B, Ouellette M.
    Nucleic Acids Res; 1999 Sep 15; 27(18):3653-9. PubMed ID: 10471733
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A, Heilbronn R, zur Hausen H.
    Cancer Res; 1990 Sep 15; 50(18):5756-60. PubMed ID: 2118419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.